
ONCOLOGY remembers Dr Franco Muggia's contribution to cancer care.

Your AI-Trained Oncology Knowledge Connection!


ONCOLOGY remembers Dr Franco Muggia's contribution to cancer care.




B-cell maturation antigen target shows promise for patients with relapsed/refractory multiple myeloma.




The Chairman and founder of MJH Life Sciences discusses the current issue of ONCOLOGY®,






While the development of immunotherapy and targeted agents has advanced treatment options for a variety of malignancies, there is still the reminder that not all regimens work in treating cancer.

Published: August 12th 2020 | Updated:

Published: October 14th 2021 | Updated:

Published: July 15th 2020 | Updated:

Published: June 16th 2020 | Updated:

Published: December 7th 2020 | Updated:

Published: September 22nd 2020 | Updated: